Application of omics data in regulatory toxicology: report of an international BfR expert workshop

Marx-Stoelting, P.; Braeuning, A.; Buhrke, T.; Lampen, A.; Niemann, L.; Oelgeschlaeger, M.; Rieke, S.; Schmidt, F.; Heise, T.; Pfeil, R.; Solecki, R.

Advances in omics techniques and molecular toxicology are necessary to provide new perspectives for regulatory toxicology. By the application of modern molecular techniques, more mechanistic information should be gained to support standard toxicity studies and to contribute to a reduction and refinement of animal experiments required for certain regulatory purposes. The relevance and applicability of data obtained by omics methods to regulatory purposes such as grouping of chemicals, mode of action analysis or classification and labelling needs further improvement, defined validation and cautious expert judgment. Based on the results of an international expert workshop organized 2014 by the Federal Institute for Risk Assessment in Berlin, this paper is aimed to provide a critical overview of the regulatory relevance and reliability of omics methods, basic requirements on data quality and validation, as well as regulatory criteria to decide which effects observed by omics methods should be considered adverse or non-adverse. As a way forward, it was concluded that the inclusion of omics data can facilitate a more flexible approach for regulatory risk assessment and may help to reduce or refine animal testing.

Zitieren

Zitierform:

Marx-Stoelting, P. / Braeuning, A. / Buhrke, T. / et al: Application of omics data in regulatory toxicology: report of an international BfR expert workshop. 2015.

Rechte

Nutzung und Vervielfältigung:
Alle Rechte vorbehalten

Export